Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.
MedPage Today on MSN
More Trial Details Reported for Novel Psoriasis Pill
Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...
白细胞介素(IL-4,Interleukin-4)是免疫系统中的一种重要调节因子,它参与感染、过敏、自身免疫和癌症等多种免疫反应。而重组IL-4(重组白介素4,AbMole,M10465)为免疫细胞的培养和分化诱导,以及细胞和动物实验提供了重要工具。AbMole为全球科研客户提供高纯度、高生物活性的抑制剂、细胞因子、人源单抗、天然产物、荧 ...
MedPage Today on MSN
Mixed but Mostly Promising Results With IL-6 Inhibitor in Uveitic Macular Edema
ORLANDO -- The investigational interleukin (IL)-6 inhibitor vamikibart led to visual improvements in uveitic macular edema in ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
New Scientist on MSN
'Weaponised' CAR T-cell therapy shows promise against solid tumours
So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...
Treatment with TNF-α inhibitors may be safer than IL-6 inhibitors in terms of cardiovascular outcomes when managing patients with RA and T2D.
Florida Supplement Company Publishes Educational Resource Examining Green Tea, Berberine, Apple Cider Vinegar, Chromium, Cinnamon, and Ginger Formulations-Compares DIY Recipes to Measured-Dose Capsule ...
The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap, but ...
Treatment with sarilumab was associated with lower all-cause mortality compared with tocilizumab in adults with rheumatoid arthritis.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈